Evidence map›Paper›PMID 31341024›Full record

ArticleThe Journal of biological chemistry2019

Exposure of

Nina Dickerhof, Vivienne Isles, Philip Pattemore, Mark B Hampton, Anthony J Kettle

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 48 citations in OpenAlex.

  1. Trial
  2. Article
  3. Microbial and host innate immune factors affecting the persistence ofFrontiers in cellular and infection microbiology · 2026
    Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Identification ofJournal of bacteriology · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Pseudomonas aeruginosa in the Cystic Fibrosis Lung.Advances in experimental medicine and biology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Nina DickerhofCentre for Free Radical Research, Department of Pathology and Biomedical Science, University of Otago Christchurch, Christchurch 8011, New Zealand. Electronic address: nina.dickerhof@otago.ac.nz.
Vivienne IslesChildren's Outreach Nursing Service, Christchurch Hospital, Christchurch 8011, New Zealand.
Philip PattemoreDepartment of Paediatrics, University of Otago Christchurch, Christchurch 8011, New Zealand.
Mark B HamptonCentre for Free Radical Research, Department of Pathology and Biomedical Science, University of Otago Christchurch, Christchurch 8011, New Zealand.
Anthony J KettleCentre for Free Radical Research, Department of Pathology and Biomedical Science, University of Otago Christchurch, Christchurch 8011, New Zealand.
University of Otago · NZChristchurch Hospital · NZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Myeloperoxidase is a major neutrophil antimicrobial protein, but its role in immunity is often overlooked because individuals deficient in this enzyme are usually in good health. Within neutrophil phagosomes, myeloperoxidase uses superoxide generated by the NADPH oxidase to oxidize chloride to the potent bactericidal oxidant hypochlorous acid (HOCl). In this study, using phagocytosis assays and LC-MS analyses, we monitored GSH oxidation in

Indexed as

Anti-Bacterial AgentsCystic FibrosisDose-Response Relationship, DrugGlutathioneGlutathione DisulfideHumansHypochlorous AcidMicrobial Sensitivity TestsNeutrophilsPhagocytosisPseudomonas aeruginosaAnti-Bacterial AgentsGlutathioneGlutathione DisulfideHypochlorous Acidcoenzyme A (CoA)cystic fibrosiscystic fibrosis transmembrane conductance regulator (CFTR)glutathioneglutathione sulfonamide (GSA)hypochlorous acidimmune responsemyeloperoxidaseneutrophilPseudomonas aeruginosa (P. aeruginosa)

Identifiers

PMID31341024
PMCPMC6737234
OpenAlexW2963429401

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.